Experienced Doctors

Medhavi Jogi, MD

Endocrinologist and Diabetologist

Dr. Jogi is Board Certified in Endocrinology as well as Board Certified in Internal Medicine. He has been practicing for years with specific focus of providing great healthcare to patients with endocrine diseases and disorders - such as Diabetes, Thyroid etc.
Request Opinion Schedule in-person visit

Dr. Jogi specializes in areas of Diabetes, Diabetes Mellitus, Lipid Metabolism Disorders and Throid Diseases. Dr. Jogi completed his Endocrinology Fellowship from Baylor College of Medicine, Houston, Texas. He is a co-founder and partner with Houston Thyroid and Endocrine Specialists, PLLC, Houston, Texas - USA.

  • Baylor College of Medicine , Houston, Texas (Endocrinology Fellowship)
  • Baylor College of Medicine, Houston, Texas (Internal Medicine-Residency)
  • Baylor College of Medicine, Houston, Texas (MD)
  • University of Texas at Austin, Houston, Texas (Bachelor of Arts in Biochemistry)

Academic appointments and clinical experience

  • Houston Thyroid and Endocrine Specialists, PLLC, Houston, TX - Co-founder and physician in practice  
  • Prescribewell - Weight management and wellness program - Chief Medical Officer
  • DermReach  - transparency in dermatology pricing- Co-Founder
  • Baylor College of Medicine, Houston, Texas - Clinical Assistant Professor
  • Baylor College of Medicine, Houston, Texas - Clinical Instructor, Ben Taub General Hospital
  • Medical Clinics of Houston, Houston, Texas - Hospitalist, St. Luke's Episcopal Hospital
  • VA Medical Center Emergency Center Physician, Houston, Texas

Certifications

  • Board Certified, Endocrinology
  • Board Certified, Internal Medicine
  • Licensed to practice medicine in the state of Texas

Professional Societies

  • American College of Clinical Endocrinology
  • Present American Diabetes Association
  • American College of Physicians

Teachings, presentations and leadership

  • American Diabetes Association Poster, San Francisco, CA: Effect of Exenatide on Palmitate-Induced Inflammation and Insulin Resistance in Skeletal Muscle.

Publications

  • Exenatide Decreases Hepatic Fibroblast Growth Factor 21 Resistance in Non-Alcoholic Fatty Liver
  • Disease in a Mouse Model of Obesity and in a Randomized Controlled Trial. Samson SL, Sathyanarayana
  • P, Jogi M, Gonzalez EV, Gutierrez A, Krishnamurthy R, Muthupillai R, Chan L, Bajaj M. Diabetologia.
  • 2011 Dec;54(12):3093-100. Epub 2011 Sep 29.
  • Effects of Combined Exenatide and Pioglitazone Therapy on Hepatic Fat Content in type 2 Diabetes. Sathyanarayana P, Jogi M, Muthupillai R, Krishnamurthy R, Samson SL, Bajaj M.
  • Obesity (Silver Spring). 2011 Dec;19(12):2310-5. Epub 2011 Jun 9
  • Jogi, M, Bajaj M. Adiponectin and Cardiovascular Disease. Cardiovascular Endocrinology. Shared
  • Pathways and Clinical Crossroads. Ed. Vivian Fonseca. Humana Press, 2009. 171-187